![](https://monteverdelaw.com/wp-content/uploads/04d2b5a5d15e29cf8f3ad81e4e5fa493.png)
Asensus Surgical, Inc. (NYSE: ASXC), relating to its proposed merger with KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ SE & Co. KG. Under the terms of the agreement, KARL STORZ Endoscopy-America, Inc., and Karl Storz California Inc. will acquire each outstanding share of Asensus Surgical stock for $0.35 in cash, without interest.